Brolucizumab, Alternating Anti-VEGFs Extends nAMD Treatment Intervals
Real-world data shows extended intervals with both brolucizumab alone or alternating anti-VEGF treatment regimens after 12 and 18 months in nAMD eyes.
Source: hcplive.com
Buxy Sinha News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Buxy Sinha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Buxy Sinha Today - Breaking & Trending Today